Directors of Beutner Laboratories
Raminder Grover, MD, D(ABMM)
Laboratory Director
Dr. Raminder Grover is a Diplomate of the American Board of Medical Microbiology. She is certified by the New York State Department of Health in Diagnostic Immunology and has years of clinical laboratory experience. She worked with Dr. Beutner for years gaining experience in diagnostic studies for autoimmune skin diseases. She specializes in skin immunopathology, immunofluorescence assays, ELISA and immunoblot assays for the diagnosis of autoimmune skin and mucous membrane diseases. She is a volunteer faculty in the Department of Dermatology at SUNY, Buffalo and also has authored research papers in skin autoimmunity, microbiology and virology.
Lakshmanan Suresh, DDS, MS, PhD, (D)ABOMP, (D)ABMLI
Technical Director
Dr. Suresh is a Diplomate of American Board of Oral and Maxillofacial Pathology and American Board of Medical Laboratory Immunology. He graduated from the School of Dental Medicine, Chennai, India. He did his post-graduate training in Oral and Maxillofacial Surgery, London, United Kingdom. He completed the advanced certification in Oral and Maxillofacial Pathology and Master’s Degree in Oral Sciences from the State University of New York at Buffalo. He has authored numerous publications in peer reviewed medical journals in the field of oral pathology and autoimmune mediated diseases.
Jill M. Kramer, DDS, PhD, (D)ABOMP
Assistant Director
Dr. Kramer received her PhD and DDS degrees from the University at Buffalo, State University of New York. She completed her specialty training in Oral and Maxillofacial Pathology at Long Island Jewish Medical Center and her post-doctoral studies at the Feinstein Institute for Medical Research. She is a fellow in the American Academy of Oral and Maxillofacial Pathologists and a diplomate in the American Board of Oral and Maxillofacial Pathology. Dr. Kramer is currently an associate professor in the Department of Oral Biology and she holds adjunct appointments within the Departments of Oral Diagnostic Sciences and Microbiology and Immunology at the University at Buffalo. Dr. Kramer conducts NIH-funded research in the area of immune dysfunction in Sjögren’s syndrome and she has authored numerous manuscripts detailing the role of immune cells in this disease. She serves as a reviewer for many scientific journals and is an active member of several scientific societies, including the American Association for Dental, Oral and Craniofacial Research, the American Association of Immunologists and the Society for Leukocyte Biology. Dr. Kramer has worked as a diagnostic immunologist and oral pathologist since 2014.
Beutner Laboratories Management Team
Kevin J. Lawson
Partner
Kevin is an accomplished biotechnology executive with formidable experience identifying and building value in promising new technologies through collaborative licensing and internal basic research. Working closely with regulatory authorities at all levels: departments of health, FDA and international bodies, he has driven development, regulatory clearance and commercialization of numerous novel reference laboratory tests and IVDs in the US and rest of world. He is responsible for validation and approval of many LDTs and 510k of more than 50 assays and medical devices.
Lakshmanan Suresh, DDS, MS, PhD
Partner
Dr. Suresh is a world-class scientist with broad experience in oral surgery, immunology, diagnostics and pathology. He is board-certified in Oral and Maxillofacial Pathology by the American Board of Oral and Maxillofacial Pathology. He is also board certificated in Laboratory Immunology by American Board of Medical Laboratory Immunology. He has authored numerous publications and book chapters, holds several patents and maintains research collaborations around the world. He is a Clinical Professor at the State University of New York at Buffalo.
Long Shen, PhD
Partner
Drawing upon scientific and medical training in Xiamen University, China and The University at Buffalo, USA, Dr. Shen has performed as translational biomedical research innovative scientific program leader for over 15 years in academic programs and private industry. Dr. Shen has made significant contributions to the identification of novel biomarkers for the early diagnosis of autoimmune disease and associated B-cell lymphomas. Dr. Shen has authored more than 25 peer-reviewed publications in high impact research journals and is co-inventor on a number patents in this field.